Symbiotec Pharmalab Limited – FDA 483, May 5, 2017
Symbiotec Pharmalab Private Limited in Pithampur, India, received a Form 483 with six observations following an inspection. The inspection revealed significant issues including missing critical records, discrepancies between documented GMP work and employee presence, and the use of an invalid test method in an API stability program. Additionally, the firm failed to conduct a full risk assessment for computer system validation, did not perform required supplier requalifications, and used an unqualified test device for packaging material release.
ID · 0c21bfeb-cc25-424f-b0e2-80e6cf079a94
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.